AKT1 and systemic sclerosis: Meanwhile, the treatment of a dual inhibitor for PI3K/Akt and mTOR signaling in an SSc mouse model also attenuated dermal fibrosis, reinforcing the role of PI3K/Akt/mTOR signaling in SSc (142).